OneSpan Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? OneSpan Inc trades at $18.26 (market cap $662.97M), while Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 5.8× OneSpan Inc's market cap, and OneSpan Inc pays a 2.89% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold OneSpan Inc for 18 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| OSPN | RLAY | |
|---|---|---|
Market Cap | $662.97M | $3.82B |
Volume | 616,882 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $18.42 | $20.75 |
52-Week Low | $10.15 | $6.03 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | $632.05M | $2.93B |
Dividend Yield | 2.89% | — |
Signals from Pluang's Aura AI — not financial advice
OSPN trades at $18.22, up 2.94% today, with a bullish technical signal from moving averages and recent earnings beats. The company shows strong profitability with a 27.76% net income margin and a reasonable P/E of 10.16. Analyst consensus is strongly positive with 10 buy ratings. Recent news highlights investor attention and a new product launch, DigipassONE, supporting growth prospects.
The outlook for OSPN is favorable given consistent earnings outperformance and solid fundamentals, though negative net cash flow and competitive pressures pose risks. Upside potential hinges on execution of its subscription revenue growth strategy and market adoption of new authentication solutions.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →